Definitive Healthcare Corp. (DH)

NASDAQ • Currency in USD

$280.00

+$0.01

0.00%

Last Update: 18 Jul 2026, 14:26

$29.86bn

Market Cap

-172.76

P/E Ratio (TTM)

—

Forward Dividend Yield

$199.07-$363.35

52 Week Range

DH Stock Price Chart

Explore Definitive Healthcare Corp. interactive price chart. Choose custom timeframes to analyze DH price movements and trends.

DH Company Profile

Discover essential business fundamentals and corporate details for Definitive Healthcare Corp. (DH) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

15 Sept 2021

Employees

782.00

Website

https://www.definitivehc.com

CEO

Kevin D. Coop

Description

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.

DH Financial Timeline

Browse a chronological timeline of Definitive Healthcare Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Aug 2026

EPS estimate is $0.04, while revenue estimate is $55.50m.

Earnings released on 7 May 2026

EPS came in at $0.06 surpassing the estimated $0.03 by +100.00%, while revenue for the quarter reached $55.93m , beating expectations by +1.65%.

Earnings released on 26 Feb 2026

EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $61.53m , beating expectations by +3.22%.

Earnings released on 6 Nov 2025

EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $60.05m , beating expectations by +0.81%.

Earnings released on 7 Aug 2025

EPS came in at $0.07 surpassing the estimated $0.05 by +40.00%, while revenue for the quarter reached $60.75m , beating expectations by +2.56%.

Earnings released on 8 May 2025

EPS came in at $0.05 surpassing the estimated $0.02 by +150.00%, while revenue for the quarter reached $59.19m , beating expectations by +1.73%.

Earnings released on 27 Feb 2025

EPS came in at $0.08 surpassing the estimated $0.07 by +14.29%, while revenue for the quarter reached $62.29m , beating expectations by +2.79%.

Earnings released on 7 Nov 2024

EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $62.70m , beating expectations by +3.49%.

Earnings released on 5 Aug 2024

EPS came in at $0.09 matching the estimated $0.09, while revenue for the quarter reached $63.74m , beating expectations by +0.91%.

Earnings released on 7 May 2024

EPS came in at $0.08 matching the estimated $0.08, while revenue for the quarter reached $63.48m , beating expectations by +0.32%.

Earnings released on 28 Feb 2024

EPS came in at $0.07 matching the estimated $0.07, while revenue for the quarter reached $65.93m , missing expectations by -0.13%.

Earnings released on 2 Nov 2023

EPS came in at $0.09 surpassing the estimated $0.06 by +50.00%, while revenue for the quarter reached $65.33m , beating expectations by +2.53%.

Earnings released on 14 Aug 2023

EPS came in at $0.08 surpassing the estimated $0.05 by +60.00%, while revenue for the quarter reached $60.96m , missing expectations by -0.10%.

Earnings released on 4 May 2023

EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $59.20m , missing expectations by -3.09%.

Earnings released on 23 Feb 2023

EPS came in at $0.07 surpassing the estimated $0.04 by +67.66%, while revenue for the quarter reached $60.60m , beating expectations by +5.15%.

Earnings released on 3 Nov 2022

EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $57.38m , beating expectations by +1.27%.

Earnings released on 4 Aug 2022

EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $54.55m , beating expectations by +1.47%.

Earnings released on 5 May 2022

EPS came in at $0.05 surpassing the estimated $0.03 by +44.93%, while revenue for the quarter reached $50.12m , beating expectations by +3.31%.

Earnings released on 23 Feb 2022

EPS came in at $0.04 falling short of the estimated $0.04 by -7.41%, while revenue for the quarter reached $46.31m , beating expectations by +3.62%.

Earnings released on 8 Nov 2021

EPS came in at $0.01 falling short of the estimated $0.02 by -47.37%, while revenue for the quarter reached $43.08m , missing expectations by -25.93%.